CDK9 inhibitor HH1
CAS No. 204188-41-0
CDK9 inhibitor HH1 ( —— )
Catalog No. M13175 CAS No. 204188-41-0
CDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 76 | Get Quote |
|
10MG | 104 | Get Quote |
|
25MG | 168 | Get Quote |
|
50MG | 246 | Get Quote |
|
100MG | 357 | Get Quote |
|
500MG | 851 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCDK9 inhibitor HH1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.
-
DescriptionCDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number204188-41-0
-
Formula Weight261.34
-
Molecular FormulaC13H15N3OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)NC1=NC(=C(S1)C(=O)C2=CC=CC=C2)N
-
Chemical Name(4-amino-2-(isopropylamino)thiazol-5-yl)(phenyl)methanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang H, et al. Cell. 2018 Nov 15;175(5):1244-1258.e26.
molnova catalog
related products
-
SEL120-34A
SEL120-34A is an ATP-competitive, selective, orally active CDK8 inhibitor that inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes with IC50 of 4.4 nM and 10.4 nM, respectively.
-
GW-8510
GW-8510 (GW8510) is apotent, selective inhibitor of CDK2 with IC50 of 10 nM; displays weak inhibition for CDK1 and CDK4 (IC50=110 and 130 nM, respectively) in vitro biochemical assays.
-
Indisulam
Indisulam (E7070) is potent, sulfonamide, cell-cycle inhibitor that possesses antiproliferative activities, causes decrease in the S phase fraction along with G1 and/or G2 accumulation in various cancer cell lines.